ROLEDUMAB
UNII Z4T52O86QV

Substance Identification & Data

This profile provides standardized clinical and technical data for Roledumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z4T52O86QV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1174008-79-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Z4T52O86QV
CAS Registry Number
1174008-79-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ROLEDUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9335
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Roledumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ROLEDUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS RHD(RHESUS BLOOD GROUP D ANTIGEN, RHD, CD240D)), HOMO SAPIENS MONOCLONAL ANTIBODY
ROLEDUMAB [INN]
ROLEDUMAB [WHO-DD]